Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Progentix Orthobiology
Bilthoven, Utrecht, Netherlands
- Ownership
- Private
- Development stage
- Other
01
Overview
Progentix Orthobiology is a Netherlands-based biotechnology company specializing in the development of osteoinductive bone graft substitutes. The company's core technology focuses on unique surface microstructures that induce bone formation without the need for added growth factors. Its flagship product, AttraX, is a synthetic ceramic bone graft used primarily in spinal fusion and orthopedic procedures. Progentix was acquired by NuVasive in 2017 to enhance its orthobiologics portfolio and is now part of Globus Medical following the NuVasive merger.
- Therapeutic areas
- RheumatologyOther
- Modalities
- DeviceBiologic
- Industry
- Implantable Medical Devices
Beyond the preview
Go deeper on Progentix Orthobiology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Progentix Orthobiology.